Pharma Business Week articles from August 2003

Pharma Business Week archives from August 2003

Older drug could have exciting new role in treatment.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Researchers at Wake Forest University Baptist Medical Center are reporting how a 15-year-old drug could have a promising new role in the treatment of rectal cancer. The drug is oxaliplatin, and when...

Enbrel is first anti-TNF therapy submitted for psoriasis.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced a supplemental Biologics License Application (sBLA) has been submitted to the U.S. Food and Drug Administration (FDA) for the...

Keppra now approved in oral solution.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved grape-flavored, dye-free Keppra (levetiracetam) oral solution (100 mg/mL), providing a new option for patients with epilepsy who prefer a liquid...

Genmab expands pipeline with hepatitis antibody.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Genmab, A/S, announced that it has in-licensed all rights to a human antibody from Connex, GmbH, a privately owned German company currently in administration, and INSERM, the French National Institute...

Market research found to be critical to blockbuster launches.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- In an increasingly competitive market, pharmaceutical companies invest more and more in market research to improve product positioning, according to a study from pharmaceutical research firm, Best...

Pharma companies raise internal awareness of issues of ethnic populations.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Internal efforts to increase sensitivity and raise awareness of diseases affecting particular ethnic populations are as important to multicultural marketers at pharmaceutical companies as external...

End users demand CAD systems with broader appeal.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Computer aided detection (CAD) system vendors in the U.S. are developing multimodality, integrated solutions to meet varied requirements of end users. These new product initiatives may increase the...

Women's pharmaceutical company secures round of financing.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- FemmePharma, Inc., a women's prescription pharmaceutical company, recently announced the completion of a round of financing. Wynnefield Capital Advisors, one of FemmePharma's existing investors,...

National Cancer Centre Singapore announces cancer diagnostics collaboration.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Genedata, a specialist for scientifically validated software systems and computational solutions for the drug discovery industry, and the National Cancer Centre Singapore (NCCS) have entered into a...

Biomarker discoveries to expand in vitro diagnostics marker for key areas.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Biomarker discovery for in vitro diagnostic applications is growing in major disease areas such as cardiovascular disease, cancer, and other significant diseases that are poorly diagnosed. Coronary...

European authorities give the go-ahead to Angeliq.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SCH, SHR) announced that the European Union has positively concluded the Mutual Recognition Procedure for Schering's novel low dose hormone replacement therapy (HRT) product...

Drug delivery company receives patent covering transdermal delivery.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Dermatrends, Inc., announced that it has received a comprehensive method patent covering the combination of virtually any ethical (prescription) drug with the Dermatrends' proprietary enhancer system...

Biotech ends second quarter on strong ground.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- "With a cascade of high-potential product approvals, excellent results in various pivotal clinical trials, a Food and Drug Administration that is committed to reducing timetables for the review process,...

Eli Lilly leads industry on charitable issues.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Eli Lilly takes the industry lead on distributing pharmaceuticals to the economically disadvantaged, according to findings emerging from the second annual Reputation Strength Study of the pharmaceutical...

Preclinical pharmaceutical marketing tops $2M.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies dedicate an average of $2 million and two full-time marketing staffers to preclinical blockbuster drug development. These resources double as projected blockbusters move...

New Media Japan, Inc., tapped as Asian representatives.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Large Scale Biology Corp. (LSBC) has appointed New Media Japan, Inc., of Tokyo as its representative to promote biopharmaceutical product partnering in Asia. New Media Japan, Inc., is known for it...

Molecular modeling study released.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- MRG, Inc., announced the release of a new market research study, "Molecular Modeling for Nanotechnology: Technologies, Applications, & Market Outlook." According to the report, although computer...

FDA gives consumers more reasons to enjoy almonds for heart health.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration's (FDA) announcement regarding a new framework to better inform consumers of science-based information about foods is good news for those who try to eat healthfully...

Max Fiore named VP, R&D at endoscopic company.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Smith & Nephew, Inc., endoscopy division, a subsidiary of Smith & Nephew, plc, (SNN) has announced the appointment of Max D. Fiore as vice president, research and development. Fiore brings more...

New Genesis Vice Chairman John J. Arlotta to lead NeighborCare.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Genesis Health Ventures, Inc., named John J. Arlotta, 53, as vice chairman. His primary responsibility will be for the company's $1.2 billion NeighborCare institutional pharmacy business. Arlotta...

HIV pipeline aimed at combating resistance.
August 4, 2003... 2003 AUG 4 - (NewsRx.com & NewsRx.net) -- Presentations at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment continue to demonstrate GlaxoSmithKline's (GSK) commitment to developing new compounds designed to combat...

Resistance data reported on tipranavir.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Phase II investigational studies presented at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment suggest that tipranavir may maintain activity against HIV that is resistant...

Drug discovery process improved with utility storage.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- 3PAR said that Infinity Pharmaceuticals has purchased and installed a 3PAR InServ Storage Server. Infinity chose 3PAR to underpin a dynamic, information-centric infrastructure for the entire...

Contract awarded to develop automated system to detect abnormal sperm.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Amnis Corporation has received a $140,000 federal contract to develop a system that detects sperm likely to cause birth defects. The 6-month phase I contract, from the National Institute of...

Alliance to develop next generation proteomics image software.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Amersham Biosciences, the life sciences business of Amersham (AHM) and Geneva Bioinformatics (GeneBio) S.A. have signed an exclusive agreement to provide researchers with the next generation of 2-D gel...

Chemoinformatics product released.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc., (PCOP) announced the release of its first Discovery Studio cheminformatics desktop product, DS Accord for Excel. This release makes...

Canadian market rights acquired to five injectable drugs.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) announced that it has acquired from Eli Lilly Canada, Inc., Canadian market and trademark rights for four proprietary products, Tazidime (ceftazidime),...

First patient enrolled in European gynecology anti-adhesion study.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced that it has enrolled the first patient in Europe using Adhibit to reduce the incidence and severity of adhesions following laparoscopic surgery in...

IND milestone payment due from Pfizer.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc., (ABGX) announced that the company will receive a milestone payment from Pfizer (PFE) triggered by Pfizer's filing of an investigational new drug (IND) application with the U.S. Food and...

Reagent toolkit launched to optimize steps in drug discovery.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Argonaut Technologies, Inc., (AGNT) announced the introduction of its Amidation Toolkit - the third in a series of resin-bound reagent products designed to accelerate pharmaceutical drug discovery...

Biotech company raises $10M in private placement.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) announced that the company has entered into definitive agreements with certain institutional investors in connection with a private placement of the company's common stock,...

Biotech company reports net loss of $0.81 per share.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., (CVTX) announced financial results for the quarter ended June 30, 2003. For the quarter ended June 30, 2003, the company reported a net loss of $22.9 million, or $0.81 per...

Earnings are 20% lower for pharmaceutical firm.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Akzo Nobel reports second quarter net earnings of EUR 201 million, 20% below the second quarter of 2002. In presenting the report, Akzo Nobel's CFO Fritz Frohlich said, "All groups were under...

Imaging agent developer reports net profit of $0.10 per share.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) announced its operating results and revenues for the third fiscal quarter and 9 months ended June 30, 2003. Revenues for the quarter were $1,429,046 as compared to...

Neurotechnology firm raises $4.3M.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cyberkinetics, Inc., announced the closing of its series A financing with an additional investment of $4.3 million. Investors include Oxford BioScience Partners, Global Life Science Ventures, and...

Oncology company raises $9.6M.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Celsion Corporation (CLN), announced that it has raised a total of $5.1 million through the exercise of outstanding common stock purchase warrants since May 28, 2003, and expects to realize gross...

Pharmaceutical firm to cooperate with request from SEC; performance reported.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) stated that it is cooperating fully with a request from the Midwest Regional Office of the U.S. Securities and Exchange Commission (SEC) to voluntarily provide...

PowderJect shares purchased, European commission inquiry resolved.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that Chiron U.K.-1 Limited, an indirect wholly owned subsidiary of Chiron, has purchased 450,000 ordinary shares of PowderJect Pharmaceuticals plc at a price of 550...

Record second quarter results reported by medical adhesives firm.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Closure Medical Corporation (CLSR) announced results for its second quarter ended June 30, 2003. Total revenues for the quarter increased 50% to $8.5 million from $5.7 million during the same...

SEC filings made by stem cell, cord blood company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cryo-Cell International, Inc., (CCCEC) announced that the company has filed its quarterly reports on Form 10-QSB for the quarters ended February 28, 2003, and May 31, 2003. The Form 10-QSB for the...

Product line expanded with Cell-Dyn system.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced the worldwide launch of the Cell-Dyn 1800 automated hematology analyzer, further enhancing the company's broad line of hematology systems. The Cell-Dyn 1800,...

FDA issues non-approvable letter for Fortigel.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that it has received a communication from the U.S. Food and Drug Administration (FDA) advising that the company's new drug application (NDA) for Fortigel...

Clinical trial software licensing agreement signed.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- DataLabs announced that Merck & Co., Inc.'s Human Health Division has selected DataLabsXC software for electronic data capture (EDC). Merck's decision to license DataLabsXC follows a successful...

Physicians favor use of hospitalists.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- According to a June 2003 poll of healthcare professionals nationwide, 81% of physicians polled favor the use of hospitalists to care for hospitalized patients. The poll was conducted by Medscape, a...

Product liability cases, related insurance coverage updated by biotech company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY) has, to date, settled five product liability cases pending against it, and three additional cases have been dismissed. Two of the three insurance companies who issued...

Insurers achieve high growth at the expense of profitability.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Despite high historical and projected growth, the entire long-term care insurance industry and many of its leading companies are destroying value, according to a new study by Conning Research and...

Allergists united in concern that managed care is dictating patient care.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Ninety-five percent of allergists believe that recent widespread changes to health insurance coverage interfere with their ability to provide the best possible care for their patients, according to...

Study reports on how companies communicate clinical trial results.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Executives at top pharmaceutical companies consider factors such as audience receptivity and location when communicating clinical study results to consumers, according to a newly released study by...

Agreement signed to acquire cancer company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- ArQule, Inc., (ARQL) announced that it has signed a definitive agreement to acquire Cyclis Pharmaceuticals, Inc., a Norwood, Massachusetts, privately held cancer therapeutics company. The...

Alcon manufacturing facility in Madrid purchased.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AMO, AVO) announced that its Spanish subsidiary has entered into an agreement with Alcon CU.S.I, S.A., a subsidiary of Alcon, Inc., (ACL), to purchase an existing Alcon...

Negotiations entered to acquire Scottish biotech firm.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- BioReliance Corporation (BREL) and Q-One Biotech Group Limited, a privately held company based in Glasgow, Scotland, announced that they have entered into a letter agreement providing for a period of...

Intellectual property position expanded in immunotherapy technology.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- CellExSys, Inc., a majority owned subsidiary of Targeted Genetics Corporation (TGEN), announced notification from the U.S. Patent and Trademark Office regarding the issuance of a patent relating to its...

Patent granted related to DEP-1 phosphatase.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Ceptyr, Inc., announced the issuance of a second patent covering a human density enhanced protein tyrosine phosphatase known as DEP-1. The patent, U.S. No. 6,552,169, is titled "Density enhanced...

Patent protection expanded to include anti-angiogenics.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX), an Ottawa-based biopharmaceutical company, announced that it was issued a new U.S. patent for antibodies that bind to and block the function of the cell adhesion...

U.S. patent granted for DIOP ligand family.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Chiral Quest, Inc., (CQST) announced that the U.S. Patent and Trademark Office has issued a patent (No. 6,576,772) covering composition of matter for chiral bisphosphine ligands derived from D-mannitol...

Davie named to board of drug development company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced the appointment of Joseph M. Davie, PhD, MD, to its board of directors. Most recently, Davie was the senior VP of research at Biogen during the period that Biogen...

Development advisory board formed at biotech company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Biolex, Inc., announced the establishment of a development advisory board (DAB) consisting of industry experts in protein manufacturing, process development, clinical and regulatory. Biolex is a...

Director resigns from cardiology drug company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cardiome Pharma Corp. announced that founder and former board chairman, Michael Walker, has resigned from the board of directors of the company for personal reasons. Walker founded Cardiome's...

Garrett named senior VP, clinical research at drug development company.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced the appointment of J. Steven Garrett as senior vice president of clinical research. Garrett resumes the leadership role in guiding clinical research at...

Healthcare banking firm adds new biotechnology expert.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Adams, Harkness & Hill announced that it has strengthened its healthcare banking practice by naming Tucker Kelly as a vice president of its group. Tucker will focus on the firm's biotechnology...

New additions to senior management team made at biotech firm.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced the appointment of Graham Burton, MD, PhD, as senior VP of regulatory affairs, pharmacovigilance and project management, and Michael Vander Zwan, PhD, as VP of...

License agreement executed for rights to ricin vaccine technology.
August 11, 2003... 2003 AUG 11 - (NewsRx.com & NewsRx.net) -- DOR BioPharma, Inc., announced it has executed an exclusive worldwide license agreement with the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) to license issued U.S....

New theory suggests that human metabolism works like a Pachinko pinball machine.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Scientists from Imperial College London and AstraZeneca have advanced a new theory that animal and human metabolisms often work like a Japanese Pachinko-type pinball machine. The researchers used...

National trial set to study Avonex combination therapy.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- The Cleveland Clinic announced that investigators have begun enrolling patients in the Avonex (interferon beta-1a) Combination Trial (ACT). The study will investigate the safety and effectiveness...

Licensing alliance to develop cancer, AIDS drug candidates in Asia.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Crimson Pharmaceutical, Ltd., (Hong Kong), the parent company of Crimson Pharmatech USA, announced an agreement to license three drug candidates from a California based company, Octamer, Inc. The...

Partnership created to ensure safer pharmaceutical care.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- ChainDrugStore.net, a secure information network for the $400 billion retail pharmacy industry, announced that it has formed a strategic partnership with the National Pharmacy Technician Association...

Complete remission of tumors reported with arginine deiminase.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Phoenix Pharmacologics, Inc., reported results of a phase II clinical study with a protein known as arginine deiminase (ADI). This enzyme degrades the amino acid arginine, which circulates in the...

Report: Healthcare M&A dollar volume surges in the second quarter.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- During the second quarter of 2003, M&A deal volume in the healthcare industry remained basically flat, with a 2% dip in transactions from the first quarter of 2003 and a 7% decrease from the second...

FDA grants approval for combination ear infection treatment.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Alcon, Inc., (ACL) has received approval from the U.S. Food and Drug Administration (FDA) to market Ciprodex Otic for topical treatment of a middle ear infection known as acute otitis media with...

Speciality pharmaceutical company acquires exclusive rights to Alzheimer drug.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Savient Pharmaceuticals, Inc. has announced that it has acquired exclusive rights from Marco Hi-Tech JV Ltd. to exclusively market in the United States and Europe Huperzine-A, a product for the...

Eurand signs agreement with leading Japanese pharmaceutical company.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Eurand, a specialty pharmaceutical company, announced that it has signed an agreement that will result in the company's first direct product sales in Japan. The agreement, which was signed with...

Inflazyme licenses antithrombotic catheter coating.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Inflazyme Pharmaceuticals, Ltd., (IZP) announced that it has entered into an agreement with Spire Corp. of Bedford, Massachusetts, to provide Inflazyme's antithrombotic technology for use with selected...

Sale of DR-70 begins in Australia, New Zealand.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL) announced that AMDL Australia Pty., Ltd., AMDL's distributor, has begun the sale of the DR-70 cancer detection test in Australia and New Zealand. Australia's Therapeutic Goods...

ECG services company inks $6 million agreement with pharmaceutical company.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- eResearchTechnology (eRT), Inc., (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced it has received an agreement for more than $6 million in...

University of Washington licenses diagnosis and treatment method for bacteria.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- The University of Washington has signed an exclusive license with ActivBiotics, Inc., of Lexington, Massachusetts, to allow the company to use knowledge and technology developed by Dr. Allan Shor of...

Agreement signed by medical device companies.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Michael D. Dale, president and CEO of ATS Medical, Inc., (ATSI) announced that ATS and Centerpulse USA Holding Co. have entered into an agreement under which ATS would pay Centerpulse $12.0 million in...

Drug delivery manufacturer to collaborate with pan-European generic company.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Inyx, Inc., (IYXI), a development and contract manufacturer of specialized drug delivery pharmaceutical products with a focus on pursuing strategic investment opportunities within the pharmaceutical...

New $32M information technology outsourcing agreement signed with pharma firm.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- ACS announced the signing of an information technology (IT) outsourcing agreement with the global pharmaceutical corporation GlaxoSmithKline (GSK). Under the 5-year, $32 million agreement, ACS will...

Online marketing revival initiated by pharmaceutical company.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline plc (GSK) has implemented a campaign to identify potential partners in collaboration with its online partnering exchange, Pharmalicensing, Ltd. "Although GSK's contract breaks the...

Royalty rate transaction completed between pharmaceutical firms.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced that it has completed its previously announced transaction with Eli Lilly and Company (LLY), through which Cubist purchased a 1% point reduction in the...

Company entering medical sector announces name change.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Corniche Group Incorporated (CNGI) said shareholders approved its change of the corporation's name to Phase III Medical, Inc. The company believes that Phase III Medical, Inc., is an appropriate...

Pharmaceutical company provides shareholder update.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Chiral Quest, Inc., (CQST) provided an update on the progress of the company. Alan D. Roth, president and CEO of Chiral Quest, said he wishes to thank his fellow shareholders for their continued...

Wartner Wart Removal rights acquired for North America, Dominican Republic.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- LDS Consumer Products (LDS) announced it has completed the purchase of the North American and Dominican Republic rights to Wartner Wart Removal System from Wartner Medical Products, Amsterdam,...

Draxis completes pharmaceutical unit divestiture worth about $19 million.
August 18, 2003... 2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Draxis Health, Inc., (DRAX), a specialty pharmaceuticals company, has completed the divestiture of its Canadian pharmaceutical sales and marketing division, Draxis Pharmaceutica, with the sale to Shire...